Education
B.S., Massachusetts Institute of Technology
Brigham & Women's Hospital / Massachusetts General Hospital Harvard Medical School
Emergency MedicineBrigham & Women's Hospital / Massachusetts General Hospital Harvard Medical School
Bellevue Hospital Center - NYU School of Medicine
Medical ToxicologyM.S., New York University
MD, UCSF School of Medicine
Biography
- Dr. Manini is board certified in Emergency Medicine and Medical Toxicology. His research interests include a wide variety of health services and clinical research to characterize and evaluate adverse cardiovascular events following drug overdose, poisoning, and acute chest pain. He receives research support from the National Institutes of Health Clinical LRP program and received the 2008 Speaker's Fund Award: Towards the Science of Patient Care, by the City of New York.
Awards
2006 -
Department Award
Emergency Medicine, MGH Clinical Research Day2006 -
Best Oral Presentation
SAEM New England Regional Meeting2006 -
Best Resident Abstract Finalist
SAEM Annual Meeting2004 -
Wuerz Scholarship for Emergency Medicine Research
Publications
Manini AF, Ilgen J, Noble VE, Bamberg F, Koenig W, Bohan JS, Hoffmann U. Derivation and validation of a sensitive IMA cutpoint to predict cardiac events in patients with chest pain. Emerg Med J 2009;: in press.
Manini AF, Dannemann N, Brown D, Butler J, Bamberg F, Nagurney JT, Nichols J, Hoffmann U. Likelihood classification versus risk stratification in acute chest pain. Am J Emerg Med 2009;: in press.
Manini AF, McAfee AT, Noble VE, Bohan JS. Prognostic value of the Duke treadmill score for emergency department patients with chest pain. J Emerg Med 2009;: in press.
Manini AF, Hoffman RS, McMartin K, Nelson LS. Relationship between serum glycolate and falsely elevated lactate in severe ethylene glycol poisoning. J Analytical Toxicol 2009; 33: 227-229.
Manini AF, Dannemann N, Brown DM, Butler J, Bamberg F, Nagurney JT, Nichols JH, Hoffmann U. Limitations of risk score models in patients with acute chest pain. Am J Emerg Med 2009; 27(1): 43-48.
Kim H, Manini AF, Nelson LS. Methadone-associated sudden cardiac death?. Am J Med 2008; 121: e11.
Kam A, Manini AF, Nelson LS. First, remove the offending agent. Am J Cardiol 2008; 102: 370-371.
Wu S, Pearl-Davis M, Manini AF, Hoffman RS. Use of antipsychotics to treat cocaine toxicity?. Acad Emerg Med 2008; 15(1): 105.
Manini AF, Nelson LS, Hoffman RS. Alcoholic ketoacidosis in an 11 year-old boy. Pediatric Emergency Care 2008; 24(3): 170-171.
Smith S, Manini AF, Szekely T, Hoffman RS. Bedside detection of urine Beta-hydroxybutyrate in diagnosing metabolic acidosis. Acad Emerg Med 2008; 15(8): 751-756.
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Manini did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
3 East 101st Street Floor 2 Room 207
New York, NY 10029